Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$0.28 - $1.16 $30,322 - $125,619
108,293 Added 424.91%
133,779 $44,000
Q1 2024

May 15, 2024

BUY
$1.06 - $1.67 $27,015 - $42,561
25,486 New
25,486 $29,000
Q3 2023

Nov 13, 2023

BUY
$1.61 - $2.54 $83,702 - $132,052
51,989 New
51,989 $94,000
Q1 2022

May 17, 2022

SELL
$2.83 - $8.69 $46,140 - $141,681
-16,304 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$8.31 - $14.92 $135,486 - $243,255
16,304 New
16,304 $135,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Mirabella Financial Services LLP Portfolio

Follow Mirabella Financial Services LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

News

Stay updated on Mirabella Financial Services LLP with notifications on news.